Clinical Trial Update: Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intravenous versus intracoronary administration of Abciximab in ST-elevation myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Abciximab (abciximab)

Snippet

Sponsor: University of Leipzig | Conditions: ST-elevation Myocardial Infarction | Phase 3 | Status: COMPLETED